Quadrant Capital Group
ADPT icon

Quadrant Capital Group’s Adaptive Biotechnologies ADPT Stock Holding History

Quadrant Capital Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$212K Buy
+8,396
New +$206K 0.01% 1178
2026
Q2 		– Sell
-8,396
Closed -$117K – 1264
2026
Q1 		$117K Hold
8,396
– – ﹤0.01% 1440
2025
Q4 		$136K Sell
8,396
-480
-5% -$7.83K ﹤0.01% 1405
2025
Q3 		$133K Buy
+8,876
New +$108K ﹤0.01% 1403
2025
Q2 		– Sell
-9,635
Closed -$71.6K – 1352
2025
Q1 		$71.6K Buy
9,635
+759
+9% +$5.83K ﹤0.01% 1611
2024
Q4 		$53.2K Hold
8,876
– – ﹤0.01% 1378
2024
Q3 		$45.4K Hold
8,876
– – ﹤0.01% 1498
2024
Q2 		$32.1K Buy
8,876
+8,287
+1,407% +$26.3K ﹤0.01% 1638
2024
Q1 		$1.89K Buy
+589
New +$2.28K ﹤0.01% 2523
2023
Q4 		– Sell
-125
Closed -$682 – 2694
2023
Q3 		$682 Sell
125
-1,090
-90% -$7.21K ﹤0.01% 2530
2023
Q2 		$8.15K Sell
1,215
-343
-22% -$2.55K ﹤0.01% 2076
2023
Q1 		$13.8K Buy
1,558
+192
+14% +$1.69K ﹤0.01% 1880
2022
Q4 		$10.4K Buy
1,366
+201
+17% +$1.56K ﹤0.01% 1927
2022
Q3 		$8K Sell
1,165
-38
-3% -$358 ﹤0.01% 1948
2022
Q2 		$10K Buy
1,203
+432
+56% +$3.8K ﹤0.01% 1635
2022
Q1 		$10K Buy
+771
New +$12.1K ﹤0.01% 1625
2021
Q4 		– Sell
-7
Closed – – 2485
2021
Q3 		$0 Buy
+7
New +$253 ﹤0.01% 2479
2021
Q2 		– Sell
-5
Closed – – 2392
2021
Q1 		$0 Buy
5
+2
+67% +$108 ﹤0.01% 2374
2020
Q4 		$0 Buy
+3
New +$155 ﹤0.01% 2280

Other funds holding ADPT

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
Edge Wealth Management
Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Leeward Financial Partners
Leeward Financial Partners Bellevue, Washington $388M AUM 19.79% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $955M AUM 18.67% 1-Year Est. Return
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Warsaw $291M AUM 52.67% 1-Year Est. Return

Quadrant Capital Group's ADPT Position: Q3 2026 in Review

Quadrant Capital Group opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 8,396 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #1178 among its holdings. This is a return to the name: Quadrant Capital Group previously reported a position in ADPT as recently as Q1 2026.

Quadrant Capital Group first reported a position in ADPT in Q4 2020 and has held it in 19 quarters since. 44 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Quadrant Capital Group held 8,396 shares of Adaptive Biotechnologies worth $212K as of Q3 2026.
  • Adaptive Biotechnologies was a new Quadrant Capital Group position in Q3 2026.
  • Adaptive Biotechnologies made up 0.01% of Quadrant Capital Group's portfolio in Q3 2026, its #1178 holding.
  • Quadrant Capital Group first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 19 quarters since.
  • 44 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Quadrant Capital Group's 13F filing for Q3 2026, filed 20 Oct 2026.